EcoDrugPlus

60s Ribosomal Protein L34

Ensembl ID : ENSSTUG00000037433
Gene Symbol: LOC115198628
3 Cross references
356 Possible Orthologues:

60s Ribosomal Protein L34

Ensembl ID : ENSSTUG00000050137
Gene Symbol: LOC115194089
3 Cross references
356 Possible Orthologues:

60s Ribosomal Protein L35

Ensembl ID : ENSSTUG00000010753
Gene Symbol: LOC115160002
3 Cross references
241 Possible Orthologues:

60s Ribosomal Protein L35a

Ensembl ID : ENSSTUG00000023585
Gene Symbol: LOC115162872
3 Cross references
448 Possible Orthologues:

60s Ribosomal Protein L35a

Ensembl ID : ENSSTUG00000001966
Gene Symbol: LOC115205847
3 Cross references
446 Possible Orthologues:

60s Ribosomal Protein L36

Ensembl ID : ENSSTUG00000051021
Gene Symbol: LOC115192169
3 Cross references
362 Possible Orthologues:

60s Ribosomal Protein L36

Ensembl ID : ENSSTUG00000028053
Gene Symbol: LOC115158825
3 Cross references
395 Possible Orthologues:

60s Ribosomal Protein L37

Ensembl ID : ENSSTUG00000021262
Gene Symbol: LOC115164207
3 Cross references
374 Possible Orthologues:

60s Ribosomal Protein L37-Like

Ensembl ID : ENSSTUG00000029177
Gene Symbol: LOC115200439
3 Cross references
377 Possible Orthologues:

60s Ribosomal Protein L39

Ensembl ID : ENSSTUG00000002038
Gene Symbol: LOC115205061
3 Cross references
561 Possible Orthologues:

60s Ribosomal Protein L4-B-Like

Ensembl ID : ENSSTUG00000014130
Gene Symbol: LOC115192966
3 Cross references
338 Possible Orthologues:

60s Ribosomal Protein L4-B-Like

Ensembl ID : ENSSTUG00000010410
Gene Symbol: LOC115197743
3 Cross references
338 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).